|
Regulations &
Codified CSA > CFR > Section 1308 > Section 1308.15
This page includes changes
to the Code of Federal Regulations since April 1, 2009. View
Key.
Section 1308.15 Schedule V.
(a) Schedule V shall consist of the drugs and other substances, by whatever official name,
common or usual name, chemical name, or brand name designated, listed in this section.
(b) Narcotic drugs. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs and their salts, as set
forth below:
(1) [Reserved]
* * * *
*
(c) Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound,
mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as
the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include
one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the
compound, mixture, or preparation valuable medicinal qualities other than those possessed by
narcotic drugs alone:
(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
grams.
(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
grams.
(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms
of atropine sulfate per dosage unit.
(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.
(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
atropine sulfate per dosage unit.
(d) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any
material, compound, mixture, or preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous system, including its salts, isomers
and salts of isomers:
| (1)
Pyrovalerone
|
1485
|
| (2) [Reserved]
|
(e) Depressants. Unless specifically exempted or excluded or unless listed in
another schedule, any material, compound, mixture, or preparation which contains
any quantity of the following substances having a depressant effect on the
central nervous system, including its salts:
(1) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] 2782
(2) [Reserved]
(1) Lacosamide
[(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]-- 2746
(2) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]--2782
[39 FR 22143, June 20, 1974, as amended at 43 FR 38383, Aug. 28, 1978; 44 FR 40888, July 13,
1979; 47 FR 49841, Nov. 3, 1982; 50 FR 8108, Feb. 28, 1985; 52 FR 5952, Feb. 27, 1987; 53 FR
10870, Apr. 4, 1988; 56 FR 61372, Dec. 3, 1991; 67 FR 62370, Oct. 7, 2002]
NOTICE: This is an
unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).
|